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Micropatterned Cell–Cell Interactions Enable
Functional Encapsulation of Primary
Hepatocytes in Hydrogel Microtissues
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Joanne H. Huang, BS,3 and Sangeeta N. Bhatia, PhD2,4–7
Drug-induced liver injury is a major cause of drug development failures and postmarket withdrawals. In vitro
models that incorporate primary hepatocytes have been shown to be more predictive than model systems which
rely on liver microsomes or hepatocellular carcinoma cell lines. Methods to phenotypically stabilize primary
hepatocytes ex vivo often rely on mimicry of hepatic microenvironmental cues such as cell–cell interactions and
cell–matrix interactions. In this work, we sought to incorporate phenotypically stable hepatocytes into three-
dimensional (3D) microtissues, which, in turn, could be deployed in drug-screening platforms such as multiwell
plates and diverse organ-on-a-chip devices. We first utilize micropatterning on collagen I to specify cell–cell
interactions in two-dimensions, followed by collagenase digestion to produce well-controlled aggregates for 3D
encapsulation in polyethylene glycol (PEG) diacrylate. Using this approach, we examined the influence of
homotypic hepatocyte interactions and composition of the encapsulating hydrogel, and achieved the maintenance
of liver-specific function for over 50 days. Optimally preaggregated structures were subsequently encapsulated
using a microfluidic droplet-generator to produce 3D microtissues. Interactions of engineered hepatic microtissues
with drugs was characterized by flow cytometry, and yielded both induction of P450 enzymes in response to
prototypic small molecules and drug–drug interactions that give rise to hepatotoxicity. Collectively, this study
establishes a pipeline for the manufacturing of 3D hepatic microtissues that exhibit stabilized liver-specific
functions and can be incorporated into a wide array of emerging drug development platforms.
Introduction
Amajor cause of clinical trial failures and postmarketdrug withdrawals is unexpected liver toxicity. These
failures late in drug development not only impact patient
safety but also represent a significant economic loss. In vitro
cell-based models have the potential to rapidly and cost
effectively provide early feedback in the drug development
process in order to identify toxic candidates for compound
prioritization. However, the capacity of these assays to
predict clinical observations depends critically on the
functional activities of the cell types used in the model
platforms. While hepatocellular carcinoma-derived cell
lines grow readily in culture, they are inadequate in vitro
models for liver drug metabolism due to low cytochrome
P450 (CYP450) enzyme activity,1 unresponsiveness to in-
duction,2 and reduced sensitivity to hepatotoxins.3 Thus,
primary hepatocytes are the preferred cell-based model for
drug development applications, yet these cells typically
undergo a rapid loss of differentiated function and viability
when cultured ex vivo.4–6 This challenge has led to the de-
velopment of various approaches to stabilize primary he-
patocyte functions by recreating some of the architectural
and microenvironmental stimuli that surround hepatocytes
in vivo, such as providing neighboring cells, extracellular
matrix (ECM), and soluble factors.4,5 In addition to so-
called two-dimensional (2D) systems, there are a variety of
three-dimensional (3D) manipulations that have also shown
promise, including spheroids,7–9 sandwich gels,10,11 porous
scaffolds,12,13 or encapsulation in natural or synthetic hy-
drogels.14–16 The premise of the present study is that the
ideal 3D culture platform for drug studies should be ame-
nable to high-throughput assay development and, therefore,
amenable to robust miniaturization.
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Miniaturization of cell-laden hydrogels into < 250mm units,
called microtissues, is a promising approach to tissue engi-
neering that provides several distinct advantages over both
scaffold-free 3D culture (i.e., spheroids) and conventional
hydrogels: (1) In contrast to spheroids or other scaffold-free
systems, the cell-encapsulating hydrogel serves a shear-
protective function during perfusion, spinner culture, or gen-
eral handling.17–19 (2) The hydrogel also prevents aggregation
even during culture in small volumes so that the transport of
oxygen and nutrients is not limiting.17,20 (3) Manipulation of
scaffold chemistry enables controlled tuning of mechanics21 or
other aspects of the microenvironment, such as entangled
whole ECM proteins,22 adhesive peptides,14,23,24 or tethered
cell signaling factors.25,26 Thus, conditions can be adjusted for
optimal cell survival and function,27 creating prestabilized
microtissue units for downstream handling. (4) Finally, com-
pared with conventional millimeter-scale hydrogels cultured
in well plates, microtissues are modular, offering expanded
versatility for experimental manipulation and analysis. For
example, we have previously described the continuous mi-
crofluidic fabrication of polyethylene glycol (PEG) hydrogel
microtissues, and the subsequent use of biochemical encoding
to direct the formation of patterned tissues from a collection of
individual microtissues.28 We have also shown that due to their
miniaturized format, microtissues are amenable to multi-
plexed29 and high-throughput flow analysis,22 bypassing more
time-consuming readouts such as confocal microscopy.30
While these earlier studies have focused on modeling the
diseased state of tumor biology, here we seek to apply mi-
crotissues to primary mammalian cells and the area of hepatic
tissue engineering. There has also been considerable interest
in using microtissues as building blocks for bottom-up as-
sembly of patterned tissues28,31,32 and packed-reactor-like
devices.33–35 However, these studies have yet to be extended
to primary hepatocytes, thus far incorporating only the more
easily cultured but phenotypically distorted hepatic cell lines.
Here, we report the fabrication of microtissues comprising
primary mammalian hepatocytes that can be mass-produced
for drug development applications. To stabilize hepatocyte
function post-isolation, we first developed a method to form
small (< 10-cell) aggregates by patterning hepatocytes on
collagen microislands and then detaching the confluent is-
lands. These micropatterned cell–cell interactions enabled
hepatocyte survival in bulk PEG hydrogels without adhesive
peptides, as well as in 100mm microtissues, which were
produced en masse by continuous microfluidic droplet-based
cell encapsulation. Hepatic microtissues exhibited hepato-
cellular activity as characterized by albumin production and
species-specific induction of CYP450 drug metabolism en-
zymes. Lastly, leveraging the inducibility of the primary
hepatocytes, we demonstrate that hepatic microtissues can be
used to detect hepatotoxicity and drug–drug interactions.
Materials and Methods
Plate patterning
Topographically patterned polydimethylsiloxane (PDMS;
Dow Corning) masking molds that defined collagen micro-
islands were cast from silicon masters. Standard photolith-
ographic methods were used to fabricate the masters with
50 mm tall raised circular pillars of SU-8 2050 photoresist
(Microchem). Intermediate PDMS ‘‘negatives’’ were cast
from the master and coated with (tridecafluoro-1,1,2,2-
tetrahydrooctyl)-1-trichlorosilane (UCT Specialties) for 1 h
in a vacuum desiccator. Final PDMS masking molds were
then cast from the negatives to again have raised pillars, and
cut into appropriate discs to fit into six-well plates.
Ultra-Low attachment six-well plates (Corning) were
coated with 0.15 mg/mL Type I collagen (rat tail; BD
Biosciences) at 37C for 1 h. Wells were rinsed with deio-
nized water and dried with nitrogen. PDMS masking molds
were carefully placed into each well, using gentle pressure
to ensure that all parts of the pattern adhered to the well, and
the entire plate was subjected to air plasma treatment (SPI
Supplies) for 15 s. Nonpatterned control plates meant to
have a homogenous collagen surface coating did not un-
dergo this last step. Masking molds were removed from
wells for reuse, and plates were sterilized by 15 min of UV
exposure before use.
Cell culture and puck formation
Hepatocytes were isolated from 2- to 3-month-old adult
female Lewis rats as previously described.36 Hepatocyte
culture medium consisted of Dulbecco’s Modified Eagle
Medium (DMEM; Invitrogen) with 10% fetal bovine serum
(Invitrogen), 0.5 U/mL insulin (Lilly), 7 ng/mL glucagon
(Bedford Laboratories), 7.5 mg/mL hydrocortisone (Sigma),
10 U/mL penicillin (Invitrogen), and 10 mg/mL streptomy-
cin (Invitrogen). J2-3T3 fibroblasts were cultured in DMEM
with 10% bovine serum (Invitrogen), 10 U/mL penicillin,
and 10 mg/mL streptomycin. mCherry J2-3T3 fibroblasts
were generated by ViroMag R/L (Oz Biosciences)-mediated
transduction of lentivirus containing mCherry under control
of the EF-1 alpha promoter (Promega). Transduced mCherry
fibroblasts were subsequently selected by puromycin fol-
lowed by fluorescence-activated cell sorting. All cells were
cultured in a 5% CO2 humidified incubator at 37C.
To seed freshly isolated hepatocytes, cells were first pel-
leted at 50 g for 5 min and resuspended in hepatocyte medium
without serum at a cell density of 2· 106 hepatocytes/mL.
One milliliter of this suspension was added to each well of a
patterned or nonpatterned six-well plate. Hepatocytes were
allowed to attach for 2 h to any adhesive regions of the plate
in the incubator, with gentle linear shaking every 15 min to
re-disperse unattached cells. The progress of seeding was
monitored under a microscope. After microislands were
seeded to confluence, each well was rinsed twice with 2 mL
of medium to remove any remaining unattached cells. Cell
number on each island was manually counted at 3 h after
initial plating, when cells were firmly attached but individual
cell borders could be easily distinguished. For hepatocyte-
only pucks, the seeded cells were then cultured in 1 mL of
hepatocyte culture medium with serum overnight. To form
pucks that contain both hepatocytes and fibroblasts, J2-3T3
cells were then added to each well (0.5· 106 cells in 1 mL
hepatocyte medium) and allowed to seed overnight, with
gentle shaking every 15 min for the first 2 h.
Encapsulation in bulk PEG gels
Hepatocytes that had been cultured on patterned or non-
patterned plates for 24 h were detached using 2 mg/mL colla-
genase (Type IV; Invitrogen) in DMEM. Within 5 min,
multicellular pucks lifted from the plate but did not dissociate
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into single cells. Pucks or unpatterned cells were diluted in
hepatocyte medium, pelleted (50 g, 5 min), and then re-
suspended at an effective cell density, calculated from the
number of microislands per well and the number of cells per
island, of 8· 106 cells/mL in PEG prepolymer. The pre-
polymer solution consisted of 100 mg/mL PEG-diacrylate (20
kDa; Laysan Bio) in heavy DMEM (DMEM adjusted to have a
specific gravity of 1.06 by OptiPrep density medium; Sigma)
with 1:100 v/v photoinitiator working solution (100 mg/mL
Irgacure 2959, Ciba, in n-vinyl pyrrolidone; Sigma). The ad-
hesive peptide RGDS was incorporated by also including
10 mM of Acrylate-PEG(3.4 kDa)-RGDS monomers, pre-
pared as previously described,14 in the prepolymer. For co-
encapsulation of fibroblasts with hepatocyte pucks, J2-3T3
fibroblasts were detached with 0.25% Trypsin-EDTA (In-
vitrogen), pelleted, and also resuspended in prepolymer for a
final 1:1 ratio of fibroblasts and hepatocytes (8· 106 fibroblasts
and 8· 106 hepatocytes per mL).
Disc-shaped, or ‘‘bulk’’ PEG gels were fabricated using
hydrogel polymerization apparatus previously described.37
Briefly, prepolymer solution containing cells was loaded into a
8.5 mm-diameter, 250mm-thick silicone spacer, sandwiched
between a Teflon base and a glass cover slip, and polymerized
by exposure to UV light from a spot curing system with a
collimating lens (320–390 nm, 21 mW/cm2, 12 s; Lumen Dy-
namics). Each gel was soaked in rinse media (DMEM) for 1 h to
remove any un-polymerized components and was subsequently
cultured in 0.5 mL of hepatocyte medium. All experiments
were performed with quadruplicate gels for each condition.
Microfluidic encapsulation in microtissues
Droplet-based microfluidic encapsulation devices were
fabricated as previously described.28 For microfluidic encap-
sulation, hepatocyte-only or hepatocyte-fibroblast pucks were
lifted using 2 mg/mL collagenase, pelleted (50 g, 5 min), and
then resuspended at an effective hepatocyte density of 30· 106
cells/mL in PEG prepolymer. The cell suspension was loaded
into a syringe and injected into the device at 200mL/h. Si-
multaneously, fluorocarbon oil (Fomblin Y-LVAC; Solvay
Solexis) containing 0.5% w/v Krytox 157 FSH surfactant
(DuPont) was also injected into the device as an oil phase. At a
droplet-generating nozzle, the aqueous cell suspension was
broken into 100mm-diameter droplets of cells and prepolymer
in oil, which were then continuously polymerized on chip
by exposure to UV light (320–390 nm, 500 mW/cm2, 0.5 s;
Lumen Dynamics) before exiting the device. Microtissues col-
lected from the device were separated from oil and washed on a
70mm strainer to remove any un-polymerized components. To
remove gels that did not contain any cells (due to settling of the
pucks during injection), microtissues were centrifuged at 50 g
for 5 min in a Percoll (Sigma) density medium solution (12.5mL
isotonic 1.12 g/mL density Percoll stock per mL of media).
Pelleted microtissues were resuspended in hepatocyte medium
and cultured in 40mm strainer caps (BD Falcon) as inserts for
24-well plates. All experiments were performed with quadru-
plicate wells for each condition.
Biochemical assays
Supernatant was collected every other day from bulk gels or
microtissues. Secreted albumin in the supernatant was quan-
tified by an enzyme-linked immunosorbent assay (ELISA)
kit using sheep anti-rat albumin antibodies (Bethyl Labs)
and horseradish peroxidase detection (3,3¢,5,5¢-tetramethyl-
benzidine; Invitrogen).
For enzyme induction experiments, microtissues were
pretreated with inducers for 72 h beginning at 48 h post-
encapsulation. Stock solutions of inducers were prepared in
dimethyl sulfoxide (DMSO) and diluted at 1:1000 for final
concentrations of 50 mM omeprazole (Sigma), 25 mM ri-
fampin (Sigma), and 10 mM dexamethasone (Sigma). Phe-
nobarbital (Sigma) was dissolved at 40 mM in deionized
water and diluted to a final concentration of 200mM. Ve-
hicle controls were pretreated with 72 h of either 1:1000
DMSO or 1:200 water.
CYP450 activity was assessed with luminogenic P450-
Glo CYP450 assay kits (Promega) according to vendor
instructions for nonlytic assays using cultured cells. Mi-
crotissues were incubated with Luciferin-PFBE (1:40 dilu-
tion in phenol-free DMEM), Luciferin-CEE (CYP1A1, 1:66
dilution), or Luciferin-H (CYP2C9, 1:50 dilution) for 3 h.
Processed medium samples from each strainer of micro-
tissues were collected, and luciferin metabolites were mea-
sured on a luminometer (10 s; Berthold).
Acetaminophen treatment
For hepatotoxicity experiments, microtissues were cultured
for 72 h postencapsulation and then exposed to 0–40 mM
of acetaminophen (Sigma) for 24 h. All samples contained a
final 0.8% v/v DMSO. For drug interaction experiments, mi-
crotissues were cultured for 48 h postencapsulation, exposed to
various inducers or controls for 72 h, and then dosed with
40 mM of acetaminophen in the presence of inducers for 24 h.
Large-particle flow cytometry
A high-throughput analysis of microtissue viability was
performed by first staining microtissues in suspension with
the live-dead fluorescent stains calcein AM (5mg/mL) and
ethidium homodimer (2.5mg/mL) for 15 min at 37C. Whole-
microtissue levels of fluorescence were detected using a
BioSort large particle flow cytometry (Union Biometrica) that
was equipped with a 488 nm excitation laser. Microtissues
were gated for on the basis of Time of Flight (size) and
Extinction (optical density) to exclude debris. Fluorescent
signal acquisition parameters were set as follows: Gains—
Green 3, Red 3, PMT control—Green 300, Red 700. Com-
pensation was applied to subtract 90% of the green signal
from red. Scatter plots were created using BioSorter software.
Raw data were also exported for processing with a custom
MATLAB code.
Immunohistochemistry, live-dead staining,
and imaging
For immunohistochemistry, fresh isolated hepatocytes or
hepatocyte microtissues were fixed in methanol and 10%
acetic acid and then gently pelleted in eppendorf tubes. Cell
pellets were resuspended in histogel (Thermo Scientific),
repelleted, and placed on ice for histogel gelation. Histogel-
encapsulated cell pellets were processed, embedded, and
sectioned. Sections were incubated with primary antibodies
against either pan-cytokeratin (1:800; Sigma) or arginase-1
(1:400; Sigma) and then with species-appropriate secondary
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antibodies conjugated to Alexa 488 or 555. Images were
obtained using a Nikon Ti scanning-confocal microscope.
Cell viability within bulk gels and microtissues was ex-
amined using calcein AM (5mg/mL) and ethidium homo-
dimer (2.5mg/mL) fluorescent stains (Molecular Probes;
incubated with cells for 15 min at 37C) to stain live and
dead cells, respectively. Images were acquired using a Ni-
kon Ellipse TE200 inverted fluorescence microscope and
CoolSnap-HQ Digital CCD Camera. MetaMorph Image
Analysis Software was used to uniformly adjust brightness/
contrast, pseudocolor, and merge images.
Results
Control and uniformity of hepatocyte patterning
Both homotypic and heterotypic cell–cell interactions
have been reported to modulate the function of primary
hepatocytes in patterned 2D culture38–40 as well as in vari-
ous 3D culture systems.14,15,41 Based on these reports, we
hypothesized that in order to establish a microtissue system
that supports functional primary hepatocytes, it would be
critical to facilitate physical cell–cell contacts. Thus, we
chose to preaggregate hepatocytes into small (< 100 mm)
multicellular units before 3D encapsulation of the cells.
Furthermore, we sought to do so in a manner that could
produce units with narrow-sized dispersity for downstream
microfluidic processing (i.e., for consistent flow), and was
easily scalable to millions of aggregates. We investigated an
approach in which hepatocytes were seeded into clusters on
2D micropatterns, allowed to form cell–cell contacts, and
then detached as aggregates. To direct cell seeding, collagen
micro-islands were patterned on tissue culture plates using a
soft lithography process39 in which a layer of adsorbed
collagen is masked by contact with a PDMS mold (Fig. 1a).
FIG. 1. Hepatocyte puck formation and detachment from patterned collagen microislands. (A) Schematic representation
illustrating the definition of adhesive collagen islands on plastic, hepatocyte seeding and spreading over 24 h, and de-
tachment with collagenase. (B) Phase images showing (i–iii) polydimethylsiloxane (PDMS) molds to define island size,
(iv–vi) primary rat hepatocytes initially seeded on the islands, (vii–ix) confluent hepatocyte islands after 24 h of culture, and
(x–xii) detached pucks. All scale bars are 200mm. (xii–xv) Histogram of number of the hepatocytes in each size of puck as
counted 3 h postseeding. Color images available online at www.liebertpub.com/tea
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Protruding PDMS posts of various sizes (50, 75, and 100mm
diameters) (Fig. 1b, i–iii) were used to protect collagen in
contacted regions from plasma ablation, resulting in 50–
100 mm circles of remaining collagen. This range of island
sizes was selected to be compatible with subsequent en-
capsulation in hydrogels as small as 100 mm in diameter.
Freshly isolated primary hepatocytes were then seeded onto
micropatterned collagen islands of various sizes (50, 75, and
100 mm diameters). Hepatocytes densely covered and ad-
hered only to the areas of collagen microislands (Fig. 1b, iv–
vi). This patterning process was robust and scalable to large
areas (Supplementary Fig. S1; Supplementary Data are
available online at www.liebertpub.com/tea), which enabled
mass production of patterned hepatocyte clusters.
After one day of culture, (Fig. 1b, vii–ix), hepatocytes
spread to form a confluent 2D layer over each microisland.
When treated with collagenase to digest underlying collagen,
the small circles of hepatocytes, or hepatocyte ‘‘pucks,’’
detached from the plate as cohesive units (Fig. 1b, x–xii)
without dissociating into single cells, presumably due to
minimal digestion of cell surface proteins by collagenase.
Cell number in each puck, counted manually after attachment
but before cell spreading, was directly related to island area
and generally followed the Poisson distribution (Fig. 1b, xiii–
x; 5.6 – 1.7 cells for 50 mm islands, 7.9 – 2.0 cells for 75 mm
islands, and 11.8 – 2.4 cells for 100 mm islands). Since even
smaller island sizes led to many islands only capturing single
cells, all subsequent studies used pucks formed by 50 mm
islands. After removal from the collagen substrate, hepato-
cytes in freely floating pucks expressed both cytokeratin and
arginase-1 (Supplementary Fig. S2), indicating that puck
culture enabled the selection for viable hepatocytes after
fresh isolation procedures. Taken together, these results show
the advantages of controlled, 2D micropatterning, which
prompts robust and effective formation of cell–cell contacts.
Effect of homotypic contacts on 3D albumin secretion
To examine whether preaggregation of hepatocytes into
pucks improved hepatic function after encapsulation in a 3D
hydrogel, we measured the albumin secretion of the cells
within monolithic, ‘‘bulk’’ PEG gels as a gauge of hepatic
phenotype and viability. For the hydrogel scaffold material,
10% w/w PEG diacrylate (PEG-DA, 20 kDa) was chosen,
because it is (1) permeable enough to enable the diffusion of
oxygen/nutrients/proteins to and from the cells,42 (2) bio-
logically/immunologically inert, and (3) can be functiona-
lized with acrylate-containing ligands.23,43,44 As a control
condition, hepatocytes were randomly seeded in collagen-
coated but unpatterned six-well plates at 600,000 cells/well,
which was chosen to match the theoretical number of cells
that would seed in a 50mm-island patterned well assuming
5.6 hepatocytes per island. At this density, cells on the un-
patterned surfaces are able to make chance cell contacts, as
they seed in 2D and form loose cords of cells when detached
(Fig. 2a, b). Hepatocytes were randomly seeded (‘‘un-
patterned’’) or micropatterned using collagen islands for
24 h, lifted by collagenase, resuspended in hydrogel pre-
polymer, and photopolymerized into 14 mL disc-shaped gels
(Fig. 2c). Live/dead staining with calcein AM and ethidium
homodimer on the encapsulated pucks showed > 80% via-
bility after 3 h (Fig. 2d), indicating that the polymerization
process itself was not additionally cytotoxic relative to the
viability of hepatocyte pucks after detachment but before
encapsulation (*80%). Hydrogels containing hepatocyte
pucks exhibited increasing albumin secretion during the first
week after encapsulation followed by sustained secretion for
approximately 2 weeks (Fig. 2e). Albumin secretion in hy-
drogels containing pucks was more than three-fold greater
compared with control hydrogels containing unpatterned
hepatocytes at 8 days ( p = 0.0571, n= 4, Wilcoxon rank
sum test). These results demonstrate that micropatterning
hepatocytes to form hepatic pucks before encapsulation
improves hepatocyte phenotype after encapsulation in a 3D
hydrogel.
Effect of other supporting factors in 3D albumin secretion
Co-culture of hepatocytes with a second cell type,39,41 or
the presence of adhesion proteins or peptides such as
RGDS,14,15 have been previously reported to support the
maintenance of primary hepatocyte function. Thus, we ex-
plored the incorporation of heterotypic cell–cell interactions
and ECM-derived adhesive moieties into the 3D gels (Fig.
2f). To achieve the former, a single-cell suspension of J2-3T3
fibroblasts expressing constitutively fluorescent mCherry
was mixed into the prepolymer used to encapsulate hepato-
cyte pucks. Resultant gels (Fig. 2g) contained J2-3T3 fibro-
blasts (shown in blue) distributed throughout the volume of
the gel, at length scales that previous studies have demon-
strated to enable paracrine signaling through soluble factors38
(< 100mm from the nearest hepatocyte) as well as, in some
cases, immediately adjacent to hepatocytes. Adhesive moi-
eties were incorporated into gels by chemically conjugating
acrylate-functionalized RGDS peptides (10 mM) into the
hydrogel network. A 3D co-culture of fibroblasts with he-
patocyte pucks resulted in a greater than two-fold increase of
albumin production relative to hepatocyte-only controls in
the first week (Fig. 2h). More importantly, the maintenance of
albumin production over time was extended in the presence
of fibroblasts from 20 days to more than 7 weeks. Conversely,
in RGDS-containing gels compared with nonadhesive con-
trols, adhesive peptides did not significantly affect albumin
production curves whether the gels contained hepatocyte
pucks only or hepatocyte pucks with fibroblasts (Fig. 2h).
Together, these results show that supportive cues from J2-
3T3 fibroblasts but not RGDS-adhesive peptides are crucial
for long-term hepatocyte survival in this system.
Microfluidic production of primary hepatic microtissues
As shown earlier, hepatocyte pucks retain function when
encapsulated with fibroblasts in macroscopic bulk PEG hy-
drogel. Thus, we sought to miniaturize the 3D-engineered
tissue into 100mm-diameter ‘‘microtissues.’’ We produced
individual droplets of prepolymer containing cells and then
polymerized these cellular droplets to form ‘‘microtissue’’
hydrogels on-chip (Fig. 3a). Hepatocyte pucks, fibroblasts,
and photopolymerizable prepolymer were mixed to form a
combined aqueous stream that was injected into the encap-
sulation device. This aqueous stream was designed to inter-
sect with an oil stream of oxygen-permeable fluorocarbon oil
at a droplet-generating nozzle, such that prepolymer-in-oil
droplets were continuously produced. Droplets subsequently
passed under a UV light source and were polymerized within
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the device (Fig. 3b and Supplementary Video S1). Although
both microtissues and bulk gels were photopolymerized from
the same prepolymer composition, the continuous fabrication
of microtissues necessitated much higher light intensities
(500 mW/cm2 instead of 21 mW/cm2) but with only a short
exposure time of 0.5 s. Polymerized, spherical microtissues
containing multicellular pucks were collected from the out-
let of the chip. Viability of primary hepatic microtissues as
assessed by live-dead staining was similar to that of bulk-
encapsulated pucks (Fig. 3c). Consistent with the results
observed using bulk hydrogels, the presence of dispersed fi-
broblasts mixed into the gels significantly increased total
albumin produced over 16 days (Fig. 3d).
After establishing that fibroblasts play a key supportive
role in maintaining hepatocyte puck function, we explored
the impact of providing this heterotypic interaction earlier
in the process, during the first 24 h posthepatocyte isola-
tion. A previous study in 2D has shown that early physical
cell–cell contact with fibroblasts, especially in the first 18 h
postisolation, was critical to hepatocyte function compared
with if the hepatocytes received soluble signals from fi-
broblasts but were physically isolated.38 To include fibro-
blasts when hepatocytes are stabilizing in 2D, fibroblasts
were seeded onto any remaining space on the microislands
after hepatocytes had been allowed to attach for 2 h. When
unattached fibroblasts are rinsed off after 2 more hours,
95% of the resulting islands contained both cell types (Fig.
3e and Supplementary Fig. S3), and as earlier, formed
confluent circles of cells over 24 h that could be discretely
detached by collagenase to produce mixed hepatocyte-fi-
broblast pucks. Thus, by patterning co-culture pucks, we
introduce supportive fibroblasts earlier and in a closer
configuration (contact vs. paracrine), the latter of which
has been shown to improve in vivo long-term hepatocyte
function in scaled-up, patterned implants.45 We further
ensure that the two cell types do not separate during mi-
crofluidic injection due to size and density differences.
Compared with randomly seeded hepatocytes where some
cells may form large multi-cellular clusters while others
remain individual, the use of prepatterned mixed pucks
FIG. 2. Homotypic and
heterotypic cell–cell interac-
tions increase albumin secre-
tion by hepatocytes in
8.5-mm-diameter bulk
polyethylene glycol (PEG)
hydrogels. Hepatocytes were
cultured in 2D on either (A)
micropatterned islands or (B)
unpatterned collagen-coated
plates. (C) Hepatocytes were
detached from each 2D
culture format after 24 h and
encapsulated in a 3D PEG
scaffold. (D) Hepatocytes
pucks are viable within the
hydrogel as visualized
by a live-dead stain. (E)
Hepatocyte-laden gels con-
taining pucks secrete more
albumin, quantified by
ELISA, into the supernatant
than gels containing un-
patterned hepatocytes (n = 4).
(F) J2-3T3 fibroblasts were
coencapsulated along with
hepatocytes into the hydrogel,
which was modified by RGDS
adhesive peptides. (G) Epi-
fluorescence image of hepato-
cyte pucks (green, calcein)
and fibroblasts (blue, mCher-
ry) coculture within a gel. (H)
The addition of fibroblasts to
gels containing hepatocyte
pucks increases the amount
and longevity of albumin se-
cretion. Incorporated RGDS
does not have a significant
effect (n = 4). Error bars show
standard error (SEM). All
scale bars are 200mm. Color
images available online at
www.liebertpub.com/tea
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decreases the size variance of objects entering the micro-
fluidic encapsulation device, thus improving the reliability
and consistency of microtissue fabrication, while incor-
porating a greater majority of hepatocytes in stabilized
aggregates. Microtissues containing hepatocyte-fibroblast
pucks, where the two cell types were brought into contact
on the day of hepatocyte isolation, displayed the most
optimal hepatic function as measured by total amounts of
secreted albumin, producing 70% more than microtissues
containing hepatocyte pucks and fibroblasts mixed 24-h
postisolation (Fig. 3d), and, thus, were chosen for use in all
subsequent studies.
Characterization of microtissue drug metabolism
enzyme activity
Of the many metabolic functions that hepatocytes perform in
the body, xenobiotic detoxification is essential in an in vitro
model used for drug development. Microsomes, which are
vesicle-like structures reformed from fragments of endoplasmic
reticulum from homogenized hepatocytes, are commonly used
in high-throughput systems to identify enzymes involved in
drug metabolism, but lack the dynamic gene expression and
intact cellular machinery required for toxicity testing. For the
prediction of single- or multi-drug toxicity, cell-based models
are desirable, because nuclear receptors in hepatocytes modu-
late levels of enzyme activities and drug interactions. We
characterized the liver-specific drug metabolism functions of
primary hepatic microtissues by assessing their CYP450 en-
zyme activity in response to known pharmacological inducers.
Microtissues were dosed with inducers omeprazole (50mM),
dexamethasone (10mM), rifampin (25mM), or phenobarbital
(200mM) at 2 days after encapsulation. After a 72 h incubation
period, the activity of several CYP isozymes was quantified
using a luminogenic CYP450 assay. We observed levels of
CYP function induction that correlated well with the literature:
a nine-fold increase in CYP1A1 activity by omeprazole, a
seven-fold increase in CYP3A4 activity by dexamethasone, a
two-fold increase in CYP2C9 activity by rifampin, and a two-
fold increase in CYP3A4 activity by phenobarbital (Fig. 4).46–49
Microtissue platform to detect hepatotoxicity
and drug–drug interactions
To assess the suitability of primary hepatic microtissues
for 3D drug toxicity studies, we treated microtissues with
varying concentrations of the common analgesic, acet-
aminophen (APAP). Acetaminophen itself is nontoxic until
it is metabolized by P450 enzymes in primary hepatocytes,
including CYP3A4, CYP2E1, and CYP1A2,50 into the re-
active metabolite N-acetyl-p-benzoquinone imine (NAPQI).
Due to their reduced P450 activity, immortalized hepatocyte
cell lines are often highly resistant to acetaminophen hep-
atotoxicity.51 We treated primary hepatic microtissues with
acetaminophen for 24 h, and then co-stained microtissues
using calcein AM (live) and ethidium homodimer (dead).
The miniaturized 3D format of the microtissues enabled the
use of a large-particle flow cytometer for high-throughput
detection of individual microtissue viability in each treat-
ment group (Fig. 5a). Overall levels of live (green) and dead
(red) staining were measured for each microtissue in control
or APAP-exposed populations. At lower concentrations of
acetaminophen (0–15 mM), the microtissue population was
FIG. 3. Microfluidic encapsulation of hepatocyte pucks.
(A) A mixture of hepatocyte pucks and fibroblasts are en-
capsulated using a (B) microfluidic droplet generating de-
vice to polymerize *100mm-diameter spherical cell-laden
hydrogels. Scale bar = 200 mm. (C) Phase image and via-
bility staining of an individual microtissue containing sev-
eral hepatocyte-only pucks. The dotted line indicates the
edge of the hydrogel. Scale bar = 50 mm. (D) Microtissues
containing hepatocyte-fibroblast mixed pucks secrete more
cumulative albumin over 16 days than microtissues con-
taining either hepatocyte pucks only, or hepatocyte pucks
with a single-cell suspension of fibroblasts. Error bars show
standard error (SEM). n= 4 wells, *p= 0.0571, **p= 0.0286,
Wilcoxon rank sum test for pairwise comparisons. (E) He-
patocytes and fibroblasts seeded together onto micropatterned
islands to form co-cultured pucks. Fluorescent images of the
two cell types right after seeding showing the distribution of
fibroblasts onto each island. Scale bars= 200mm. Color
images available online at www.liebertpub.com/tea
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detected with generally high green (live) fluorescence and
low red (dead) fluorescence, as represented on a scatter plot
(Fig. 5b). However, after the treatment of microtissues with
40 mM APAP, the fluorescent signals of the population
shifted downward (less green) and to the right (more red),
indicating a range of degrees of cell death per microtissue
within the pool of treated microtissues. By gating to separate
fully viable microtissues from those with some level of re-
duced viability (Fig. 5c), we quantified the proportion of
viable microtissues when treated with increasing APAP
doses and observed a nonlinear toxicity ‘‘shoulder’’ below
which there was little effect, but above which hepatotoxicity
is observed. The shape of this dose curve may be attributed
to the depletion of intracellular glutathione52 and has been
observed in other primary hepatocyte systems,39,53 indicat-
ing that these microtissues faithfully detect a canonical ex-
ample of primary hepatocyte toxicity.
We next sought to explore whether the primary hepatic
microtissue-based toxicity platform could detect canonical
hepatocyte-mediated drug–drug interactions, in which in-
duction of a CYP450 enzyme by exposure to one drug leads
to more rapid metabolism of a subsequently dosed drug,
affecting its toxicity or efficacy. Since we demonstrated that
hepatic microtissues are responsive to CYP450 induction,
we subjected them to co-treatment with (1) a pharmacologic
inducer (omeprazole, dexamethasone, rifampin, or pheno-
barbital) and (2) acetaminophen. Preincubation of microtissues
with omeprazole, which is reported to induce CYP1A2,54 be-
fore treatment with acetaminophen increased the amount of
dead staining and decreased the amount of live staining com-
pared with acetaminophen-only treated microtissues (Fig. 6a)
as analyzed by large-particle flow cytometry. Pretreatment with
dexamethasone, which is known to induce CYP3A4 activity47
(Fig. 4b), also exacerbated acetaminophen-induced hepato-
toxicity (Fig. 6b). Conversely, rifampin and phenobarbital,
which are poor inducers of rat CYP3A4,47,48 did not signifi-
cantly increase acetaminophen toxicity (Fig. 6c, d). Together,
these data indicate the ability of hepatic microtissues to inte-
grate responses to multiple drugs and to detect cytochrome-
P450-mediated drug interactions.
FIG. 4. Induction of cytochrome P450 (CYP450) activity in primary hepatocyte/fibroblast microtissues. Microtissues
were exposed to inducers for 72 h before measurement of CYP450 activity using luminogenic substrates. (A) CYP1A1
activity induced by 50mM omeprazole. (B) CYP3A4 activity induced by 10 mM dexamethasone. (C) CYP2C9 activity
induced by 25mM rifampin. (D) CYP3A4 activity induced by 200mM phenobarbital. Luminescent signals were scaled
relative to uninduced vehicle controls, all groups were n= 3 wells, with 100,000 microencapsulated hepatocytes per well.
Error bars show standard error (SEM).
FIG. 5. Microtissues are susceptible to acetaminophen-elicited hepatotoxicity. (A) Live-dead staining and large particle
flow cytometry were used to detect level of toxicity on a per-microtissue basis. (B) Scatter plots of microtissue fluorescence
(green—live, red—dead) after 24 h incubation with various doses of acetaminophen. Upper left gate set based on repeated
control conditions indicates% of all microtissues in the population that do not show reduced cell viabilities (% viable
microtissues). (C) Cliff-point for APAP toxicity observed in % viable microtissue dose curve. n > 1000 microtissues in each
population. APAP, acetaminophen. Color images available online at www.liebertpub.com/tea
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Discussion
Cell-based in vitro systems capable of modeling the
response of in vivo liver tissue to toxic insults could help
reduce the number of late-stage drug development failures,
but require the optimization of in vitro culture for primary
hepatocytes. In this study, we developed a modular method
that maintains hepatocyte function using established 2D
culture paradigms to induce preaggregation of primary
hepatocytes before 3D encapsulation. Using an array of
microfabrication and microfluidic techniques, we have,
for the first time to our knowledge, encapsulated primary
hepatocytes within PEG microtissues. The initial pre-
patterning step stabilized cell–cell contacts and enabled
hepatocyte function for more than 50 days. The resulting
3D-encapsulated PEG microtissues, which exhibit induc-
ible CYP450 activity and can detect hepatotoxic drugs and
combinations, offer suitability for high-throughput studies
of primary hepatocytes.
Conventional techniques used to form 3D aggregates,
such as culturing cells in rotational suspension,20,55 or on
nonadhesive plates,56 can take multiple days to incorpo-
rate all cells, and lead to spheroids that are nonuniform in
shape and size.20,57,58 To address this problem, various
microtechnology-based methods to enhance spheroid uni-
formity have been developed,58 including hanging-drop
platforms59 or centrifugation into microwells,60 but remain
limited with regard to expense and throughput. In this
FIG. 6. Hepatic micro-
tissues detect CYP450 in-
ducer interactions with
acetaminophen toxicity. (A–
D) Flow cytometry scatter
plots of microtissues treated
with 40 mM APAP after 72 h
of induction with (A) 50mM
omeprazole, (B) 10mM
dexamethasone, (C) 25mM
rifampin, or (D) 200mM
phenobarbital. Green—
calcein, live. Red—ethidium
homodimer, dead. Omepra-
zole and dexamethasone
exacerbate acetaminophen
toxicity. (E–H) Histogram
representation of microtissue
populations, quantifying ratio
of green versus red signal
with higher ratios indicating a
higher percent of viable cells
in the microtissues. Treatment
and control groups are coded
as follows - orange: APAP
only, blue: inducer+APAP,
green: inducer only, black:
vehicle control. n> 1000 mi-
crotissues in each population,
*** indicates p-value < 10- 4
(one-way analysis of vari-
ance, Tukey post-hoc test).
Color images available online
at www.liebertpub.com/tea
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study, we have described a novel ‘‘2D to 3D’’ fabrication
method to produce such aggregates by seeding cells on
large arrays of < 100 mm micropatterned collagen islands,
and detaching intact cell aggregates from each island with
collagenase (Fig. 1). Compared with the use of thermally
responsive coatings for cell-sheet-to-spheroid formation,
which requires specialty chemical functionalization that
is not widely accessible,61 our collagen-patterned method
is simpler and more scalable especially for small aggre-
gates. The ability to easily define a range of uniform island
sizes, and hence the number of cells per aggregate and
the size of the detached pucks, illustrates that control can
be achieved over puck characteristics and homogeneity. In
contrast to other 3D aggregation methods, our protocol,
in addition, selects only adhesive hepatocytes from the
freshly isolated population of primary cells, thus filtering
out any nonviable cells. Most importantly, our method
is orders of magnitude higher in throughput compared
with hanging drop (96 or 384 spheroids/plate) or micro-
well plates (28000 spheroids/plate), especially for small
aggregates. Using our method, one six-well plate patterned
with 50 mm islands can template more than 600,000 pucks,
or *3 · 106 hepatocytes assuming five hepatocytes per
puck.
By examining the function of primary rat hepatocyte
pucks encapsulated in macroscopic PEG hydrogels, we
found that preaggregation of the hepatocytes increased the
levels of albumin secreted from cell-laden hydrogels (Fig.
2c), which is consistent with literature reports on the effects
of homotypic hepatocyte interactions.4 The addition of co-
encapsulated J2-3T3 fibroblasts into the hydrogels improved
hepatocyte performance even more, corroborating the phe-
notypic advantage gained from co-culture reported in other
culture formats (Fig. 2f).4,39–41 Notably, further functiona-
lizing the PEG hydrogel with adhesive RGDS peptides did
not have a significant effect on albumin production by en-
capsulated hepatocytes. Integrin ligation by RGDS has been
reported to confer survival to isolated hepatocytes through
the Akt pathway.62 In addition, although cellular response to
RGD can depend on how the peptide is presented (e.g.,
clustering density63), we have conjugated RGDS to 10%
PEG-DA hepatocyte-laden hydrogels using the same co-
polymerization route in the past.15 That RGDS was not
necessary for optimal hepatocyte function in the present
case may be due to cross-talk between cell–matrix and cell–
cell interaction pathways,64–66 and suggests that cell–cell
contacts established during the 2D phase of microtissue
construction were sufficient to alleviate the need for any
cell–matrix contacts in 3D, as the PEG hydrogel background
is biologically inert. Alternatively, it is possible that despite
collagenase digestion, secreted ECM molecules remain at-
tached to hepatocytes and are subsequently immobilized
during encapsulation.67
We have evaluated the function of primary hepatocytes
within PEG microtissues over several weeks, including
prolonged albumin secretion, and maintained the activity of
several major CYP450 isozymes: CYP1A1, CYP3A4, and
CYP2C9 (Fig. 4). Moreover, we have demonstrated the in-
duction of metabolic activity in response to omeprazole,
dexamethasone, rifampin, and phenobarbital. Given these
intact drug metabolism characteristics, the miniaturized 3D
format of microtissue culture enables high-throughput tox-
icity and drug–drug interaction screens. In vivo studies that
assess large numbers of compounds can be slow, expen-
sive, and require significant compound scale-up for dosing.
Advantages of the microtissue system for such toxicity
screening include being amenable to fast flow cytometry-
like fluorimetric readouts that provide population data. In
contrast to spheroid cultures, where uncontrolled aggregation
often results in large spheroids with necrotic cores,4,9,17,20
hepatic microtissues are protected from both shear and ag-
gregation, and can be cultured in small volumes without such
consequences. Thus, experiments can be designed with large
numbers of replicate microtissues to acheive statistical power
while still minimizing the amounts required of early devel-
opment compounds, which can be limiting. Furthermore,
unlike monolithic 3D tissues, our primary hepatic micro-
tissues are modular and can be integrated with a variety of
different experimental platforms. Here, we not only cultured
microtissues in a static media on a porous support, but they
could also, for example, be cultured in mixed suspension or
microfluidically perfused. Finally, microtissues containing
different types of cells could be easily combined to explore
signaling or metabolite interactions between tissues.
To illustrate the potential of primary hepatic microtissue-
based drug toxicity screening, we performed a dosing ex-
periment with the hepatotoxic drug acetaminophen (Fig. 5).
Compared with pooled biochemical assays such as MTT
assays on 2D hepatocytes,39 these data offer insights into not
only the average degree of hepatotoxicity observed, but also
the range of responses across the microtissue popula-
tion (Fig. 5b). We have also completed a 6-day drug–drug
interaction experiment (Fig. 6). Combined, these results
suggest the utility of this system for screening new drug
candidates, with the potential for longer treatment times
and complex dosing schemes (multiple doses, drug co-
treatment) that cannot be performed in short-lived liver
slices or microsomes. Future work will incorporate auto-
mated liquid handling and more specialized fluorescent in-
dicators of hepatocyte injury.68
Throughout this study, primary rat hepatocytes were used
to establish patterning and encapsulation techniques. We
and others have previously found that the qualitative rules
developed to culture primary hepatocytes often translate
cross-species from rat to human hepatocytes.4,14,15,39,45,69
Therefore, we anticipate that these methods will be ex-
tendable to primary human hepatocytes in future iterations
of our platform. It is notable that the resulting hepatic
microtissues described here accurately reflect their species-
specific origin. Specifically, microtissues displayed a seven-
fold induction of CYP3A4 by dexamethasone, which is
comparable to the fold inductions reported for rat he-
patocytes (approximately three to eight-fold from various
donors, while no induction was observed for human hepa-
tocytes47). Accordingly, dexamethasone induction increased
hepatotoxicity from acetaminophen exposure (Fig. 6b),
which is known to be metabolized through CYP3A4. Phe-
nobarbital and rifampin, in contrast, are strong CYP3A4
inducers in primary human hepatocytes but less so for rat
hepatocytes,48 consistent with our finding that phenobarbital
led to only a 2-fold induction of CYP3A4 in microtissues
(Fig. 4d). Thus, as expected, phenobarbital and rifampin did
not significantly affect acetaminophen hepatotoxicity (Fig.
6c, d). Therefore, although the hepatic microtissues
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characterized here may not be directly predictive of human
clinical outcomes, these results suggest that microtissues
derived from human hepatocytes may display human-
specific induction patterns to detect human-specific drug–
drug interactions.
We have described the maintenance of liver-specific drug
metabolism functions in 3D hepatic microtissues, enabling
early-stage screening of drug-induced liver injury and drug–
drug interactions in primary hepatocytes. The ability to use
primary hepatocytes as model cells carries the potential to
predict diverse or idiosyncratic liver responses from indi-
viduals with varying risk factors such as age, gender, ge-
netics, or underlying diseases.
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